☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Similis Bio
Similis Bio Collaboration with Novel351k to Develop Multiple Biosimilar Programs for Cancer and Autoimmune Diseases
February 14, 2023
Similis Bio Entered into a Development and License Agreement with Blau Farmaceutica to Co-Develop Four Biosimilar Programs
October 25, 2022
Load more...
Back to Home
